康惠股份：12月10日召开董事会会议

Group 1 - The core viewpoint of the article highlights that Kanghui Co., Ltd. (SH 603139) held its fifth meeting of the sixth board of directors on December 10, 2025, to discuss the proposal for the fourth extraordinary shareholders' meeting of 2025 [1] - For the first half of 2025, Kanghui's revenue composition is as follows: pharmaceutical manufacturing accounts for 60.68%, pharmaceutical distribution for 36.79%, and other businesses for 2.53% [1] - As of the report, Kanghui's market capitalization stands at 2.2 billion yuan [1] Group 2 - The article mentions that the price of Feitian Moutai has dropped by 43% over the past two years, indicating a significant change in the market dynamics for this product [1] - The report raises concerns about the sustainability of profits for distributors, suggesting that the market may be facing challenges as the "tide recedes" [1]